![]()
The sector observers continue to scrutinize the third quarter of 2022 results. Today they observe operating shortfall of $-3.709893 millions, from the , which has not specified any revenue thus far, for the respective July to September 30 2022 quarter.
It is eye-catching that, the rising entity managed to operate more economically, then in the financial period ending September 3-1 2-122. Arising from operating shortfall of $-4.408203 millions.
Because the is nevertheless emerging the revenue streams, in some manner MYMD has succeeded in the cost optimization in the third quarter of 2022 to $-3.694 millions, from the $-5.467 millions, in the third quarter of -1.
is expected to report next financial results on March 30, 2023.